Healthcare ❯ Pharmaceuticals ❯ Drug Approval
Endometriosis Treatment Clinical Trials Patient Access Ruxolitinib
NHS England plans to offer ruxolitinib to nearly 100,000 eligible people within about three months after striking a deal with Incyte.
